| Acton Psychological Associates Llc | |
|
532 Great Rd Acton MA 01720-3415 | |
| (508) 785-5518 | |
| Not Available |
| Full Name | Acton Psychological Associates Llc |
|---|---|
| Speciality | Psychologist |
| Location | 532 Great Rd, Acton, Massachusetts |
| Authorized Official Name and Position | Eleanor Kent Fulton (DIRECTOR/OWNER) |
| Authorized Official Contact | 5087855518 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Acton Psychological Associates Llc 74 Meadowview Rd Groton MA 01450-1051 Ph: (508) 785-5518 | Acton Psychological Associates Llc 532 Great Rd Acton MA 01720-3415 Ph: (508) 785-5518 |
| NPI Number | 1013419381 |
|---|---|
| Provider Enumeration Date | 03/02/2018 |
| Last Update Date | 03/02/2018 |
| Medicare PECOS PAC ID | 7214290741 |
|---|---|
| Medicare Enrollment ID | O20180417000136 |
News Archive
"Each year, three million newborns die, making up 43 percent of the world's under-five child deaths," Joy Lawn, director of global evidence and policy for Save the Children's Saving Newborn Lives, writes in an Inter Press Service opinion piece.
A team of McGill University researchers has found that young adults who perceived higher levels of social support reported fewer mental health problems.
Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.
Two separate posts in the Center for Global Health Policy's "Science Speaks" blog report on the International Treatment as Prevention conference in Vancouver. The first post recaps an update from Stephen Becker of the Bill & Melinda Gates Foundation on Tuesday "about the Foundation's treatment optimization activities," writing, "According to Becker, the Foundation acknowledges that treatment will be at the center of HIV prevention efforts, but 'no amount of treatment will obviate the need for primary prevention modalities.'"
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013419381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 7814 (Massachusetts) | Primary |
| Provider Name | Eleanor K Fulton |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1285006734 PECOS PAC ID: 3678537172 Enrollment ID: I20160204001400 |
News Archive
"Each year, three million newborns die, making up 43 percent of the world's under-five child deaths," Joy Lawn, director of global evidence and policy for Save the Children's Saving Newborn Lives, writes in an Inter Press Service opinion piece.
A team of McGill University researchers has found that young adults who perceived higher levels of social support reported fewer mental health problems.
Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.
Two separate posts in the Center for Global Health Policy's "Science Speaks" blog report on the International Treatment as Prevention conference in Vancouver. The first post recaps an update from Stephen Becker of the Bill & Melinda Gates Foundation on Tuesday "about the Foundation's treatment optimization activities," writing, "According to Becker, the Foundation acknowledges that treatment will be at the center of HIV prevention efforts, but 'no amount of treatment will obviate the need for primary prevention modalities.'"
› Verified 6 days ago
News Archive
"Each year, three million newborns die, making up 43 percent of the world's under-five child deaths," Joy Lawn, director of global evidence and policy for Save the Children's Saving Newborn Lives, writes in an Inter Press Service opinion piece.
A team of McGill University researchers has found that young adults who perceived higher levels of social support reported fewer mental health problems.
Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.
Two separate posts in the Center for Global Health Policy's "Science Speaks" blog report on the International Treatment as Prevention conference in Vancouver. The first post recaps an update from Stephen Becker of the Bill & Melinda Gates Foundation on Tuesday "about the Foundation's treatment optimization activities," writing, "According to Becker, the Foundation acknowledges that treatment will be at the center of HIV prevention efforts, but 'no amount of treatment will obviate the need for primary prevention modalities.'"
› Verified 6 days ago
Streff Associates, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 532 Great Rd, Acton, MA 01720 Phone: 978-263-0439 Fax: 978-263-5706 | |
Derick E. Vergne, Md Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 179 Great Rd Ste 201, Acton, MA 01720 Phone: 857-239-1911 Fax: 617-544-0937 | |
Njlarocque Counseling, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 525 Massachusetts Ave Ste 101f, Acton, MA 01720 Phone: 617-331-1180 Fax: 888-430-8150 | |
Derick E. Vergne Md, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 179 Great Rd Ste 201, Acton, MA 01720 Phone: 857-239-1911 Fax: 617-544-0937 | |
Corporate Eap Resources, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 184 Great Rd, Suite 3, Acton, MA 01720 Phone: 866-635-1712 Fax: 978-635-1712 | |
Vanessa Demelo Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4 Beth Cir, Acton, MA 01720 Phone: 978-201-0069 |